Recent Findings in the Posttranslational Modifications of PD-L1

Immune checkpoint therapy, such as the reactivation of T-cell activity by targeting programmed cell death 1 (PD-1) and its ligand PD-L1 (also called B7-H1 and CD274) has been found pivotal in changing the historically dim prognoses of malignant tumors by causing durable objective responses. However,...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Shu-Man, Zhou, Jie, Wang, Yun, Nie, Run-Cong, Chen, Jie-Wei, Xie, Dan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7199566/
https://www.ncbi.nlm.nih.gov/pubmed/32377193
http://dx.doi.org/10.1155/2020/5497015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7199566/
https://www.ncbi.nlm.nih.gov/pubmed/32377193
http://dx.doi.org/10.1155/2020/5497015

Ejemplares similares